Metabolites of the janus kinase inhibitor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01)

Patent

CA 2689158

The present invention provides active metablites of 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.

L'invention concerne des métabolites actifs de 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile qui modulent l'activité de Janus kinases et sont utiles dans le traitement des maladies relatives à l'activité de Janus kinases comprenant, par exemple, des maladies immunologiques, des affections cutanées, des troubles prolifératifs de myéloïde, des cancers, et d'autres maladies.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Metabolites of the janus kinase inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metabolites of the janus kinase inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metabolites of the janus kinase inhibitor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1503278

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.